Company attributes
Industry
B2X
Founder
Spun Out From
Number of Employees (Ranges)
11 – 50
Full Address
790 Memorial Drive Suite 103 Cambridge, MA 02139 United States
Total Funding Amount (USD)
2,850,000
Latest Funding Round Date
July 22, 2020
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
Vesigen develops therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company's patented technology, called ARMMs (ARRDC1 Mediated Microvesicles), enables them deliver a wide range of payloads, including RNAs (mRNA, shRNA, ribozymes), proteins (signaling proteins, enzymes, antibody fragments), and editing complexes (Cas9/gRNA) directly into the cytoplasm of target cells, expanding the universe of druggable targets.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
